CONAN: Controlled-replication ONcolytic AdeNovirus
Problema a solucionar
Immunotherapy for cancer patients with solid tumors based on oncolytic viruses.
Tecnologia
Our proposal involves the therapeutic use of mesenchymal cells that serve as carriers for an oncolytic adenovirus designed to selectively target and eliminate tumor cells while preserving healthy tissue (tumor-selective replication viruses).
Autors
Rafael Moreno, Ramon Alemany
Technology Readiness Level
TRL4
Què busquem?
Codevelopment and/or licensing out opportunities